CUSIP: 67080N101
Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
339,200,672
-
Total 13F shares
-
220,537,335
-
Share change
-
-4,189,449
-
Total reported value
-
$817,798,856
-
Put/Call ratio
-
33%
-
Price per share
-
$3.70
-
Number of holders
-
201
-
Value change
-
-$1,495,817
-
Number of buys
-
119
-
Number of sells
-
64
Quarterly Holders Quick Answers
What is CUSIP 67080N101?
CUSIP 67080N101 identifies NUVB - Nuvation Bio Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2025
-
Previous quarter:
Q2 2025
Recent filing periods for CUSIP 67080N101:
Institutional Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q3 2025
As of 30 Sep 2025,
Nuvation Bio Inc. - Common Stock (NUVB) was held by
201 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
220,537,335 shares.
The largest 10 holders included
FMR LLC, Decheng Capital LLC, BlackRock, Inc., VANGUARD GROUP INC, Laurion Capital Management LP, Omega Fund Management, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, and Nuveen, LLC.
This page lists
201
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.